These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3245677)

  • 21. Photoaffinity labeling of the Sarcoma 180 cell surface by daunomycin.
    Yee G; Carey M; Tritton TR
    Cancer Res; 1984 May; 44(5):1898-903. PubMed ID: 6713390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intercalation of daunomycin into stacked DNA base pairs. DFT study of an anticancer drug.
    Barone G; Guerra CF; Gambino N; Silvestri A; Lauria A; Almerico AM; Bickelhaupt FM
    J Biomol Struct Dyn; 2008 Aug; 26(1):115-30. PubMed ID: 18533732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of antitumor antibiotic daunomycin to histones in chromatin and in solution.
    Rabbani A; Finn RM; Thambirajah AA; Ausió J
    Biochemistry; 2004 Dec; 43(51):16497-504. PubMed ID: 15610044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A differential interaction of daunomycin, adriamycin, and N-trifluoroacetyladriamycin 14-valerate with mouse peritoneal macrophages.
    Facchinetti T; Raz A; Goldman R
    Cancer Res; 1978 Nov; 38(11 Pt 1):3944-9. PubMed ID: 212183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promotion of daunorubicin uptake and toxicity by the calcium antagonist tiapamil and its analogs.
    Kessel D; Wilberding C
    Cancer Treat Rep; 1985 Jun; 69(6):673-6. PubMed ID: 4016770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of verapamil on daunomycin cellular retention and cytotoxicity in P388 leukemic cells.
    Yanovich S; Preston L
    Cancer Res; 1984 May; 44(5):1743-7. PubMed ID: 6713377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of copper(II) ions with the daunomycin-calf thymus deoxyribonucleic acid complex.
    Spinelli M; Dabrowiak JC
    Biochemistry; 1982 Nov; 21(23):5862-70. PubMed ID: 7150531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells.
    Dano K
    Biochim Biophys Acta; 1973 Oct; 323(3):466-83. PubMed ID: 4796512
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of multi-functional liposomes containing daunorubicin and emetine for treatment of acute myeloid leukaemia.
    Myhren L; Nilssen IM; Nicolas V; Døskeland SO; Barratt G; Herfindal L
    Eur J Pharm Biopharm; 2014 Sep; 88(1):186-93. PubMed ID: 24747809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles. Circular dichroism study.
    Gallois L; Fiallo M; Garnier-Suillerot A
    Biochim Biophys Acta; 1998 Mar; 1370(1):31-40. PubMed ID: 9518541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorescent double labeling of normal and malignant hematopoietic cells by monoclonal antibodies (FITC) and anthracycline cytostatic drug (Daunomycin): a cytometric technique for analysis of drug uptake in hematopoietic cell subpopulations.
    Sedlák J; Chorváth B
    Neoplasma; 1991; 38(1):13-20. PubMed ID: 1901384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro.
    Duncan R; Kopecková-Rejmanová P; Strohalm J; Hume I; Cable HC; Pohl J; Lloyd JB; Kopecek J
    Br J Cancer; 1987 Feb; 55(2):165-74. PubMed ID: 3468994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between an anthracycline antibiotic and DNA: molecular structure of daunomycin complexed to d(CpGpTpApCpG) at 1.2-A resolution.
    Wang AH; Ughetto G; Quigley GJ; Rich A
    Biochemistry; 1987 Feb; 26(4):1152-63. PubMed ID: 3567161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.
    Huwyler J; Yang J; Pardridge WM
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1541-6. PubMed ID: 9316870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elucidation of the DNA sequence preferences of daunomycin.
    Skorobogaty A; White RJ; Phillips DR; Reiss JA
    Drug Des Deliv; 1988 Jul; 3(2):125-51. PubMed ID: 2855576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Increase in the resistance of a liposome-incorporated rubomycin-DNA complex to the action of DNAses].
    Seleva NG; Popov GA; Riabchenko NI; Dedenkov AN
    Antibiotiki; 1981 Jan; 26(1):37-40. PubMed ID: 7212681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cooperative multiple binding of bisANS and daunomycin to tubulin.
    Ward LD; Timasheff SN
    Biochemistry; 1994 Oct; 33(39):11891-9. PubMed ID: 7918408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thermodynamics of the daunomycin-DNA interaction: ionic strength dependence of the enthalpy and entropy.
    Chaires JB
    Biopolymers; 1985 Feb; 24(2):403-19. PubMed ID: 3978225
    [No Abstract]   [Full Text] [Related]  

  • 39. Differences in daunomycin retention in sensitive and resistant P388 leukemic cells as determined by digitized video fluorescence microscopy.
    Yanovich S; Taub RN
    Cancer Res; 1983 Sep; 43(9):4167-71. PubMed ID: 6871858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of daunomycin to calf thymus nucleosomes.
    Chaires JB; Dattagupta N; Crothers DM
    Biochemistry; 1983 Jan; 22(2):284-92. PubMed ID: 6824632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.